Global Nonsteroidal Anti-inflammatory APIs Market Research Report 2021

1 Nonsteroidal Anti-inflammatory APIs Market Overview

• 1.1 Product Overview and Scope of Nonsteroidal Anti-inflammatory APIs
• 1.2 Nonsteroidal Anti-inflammatory APIs Segment by Type
  • 1.2.1 Global Nonsteroidal Anti-inflammatory APIs Market Size Growth Rate Analysis by Type 2021 VS 2027
  • 1.2.2 Aspirin
  • 1.2.3 Ibuprofen
  • 1.2.4 Naproxen
  • 1.2.5 Diclofenac
  • 1.2.6 Oxapcin
  • 1.2.7 Other
• 1.3 Nonsteroidal Anti-inflammatory APIs Segment by Application
  • 1.3.1 Global Nonsteroidal Anti-inflammatory APIs Consumption Comparison by Application: 2016 VS 2021 VS 2027
  • 1.3.2 Adult
  • 1.3.3 Child
• 1.4 Global Market Growth Prospects
  • 1.4.1 Global Nonsteroidal Anti-inflammatory APIs Revenue Estimates and Forecasts (2016-2027)
  • 1.4.2 Global Nonsteroidal Anti-inflammatory APIs Production Capacity Estimates and Forecasts (2016-2027)
  • 1.4.3 Global Nonsteroidal Anti-inflammatory APIs Production Estimates and Forecasts (2016-2027)
• 1.5 Global Nonsteroidal Anti-inflammatory APIs Market by Region
  • 1.5.1 Global Nonsteroidal Anti-inflammatory APIs Market Size Estimates and Forecasts by Region: 2016 VS 2021 VS 2027
  • 1.5.2 North America Nonsteroidal Anti-inflammatory APIs Estimates and Forecasts (2016-2027)
  • 1.5.3 Europe Nonsteroidal Anti-inflammatory APIs Estimates and Forecasts (2016-2027)
  • 1.5.5 China Nonsteroidal Anti-inflammatory APIs Estimates and Forecasts (2016-2027)
  • 1.5.5 Japan Nonsteroidal Anti-inflammatory APIs Estimates and Forecasts (2016-2027)

2 Market Competition by Manufacturers

• 2.1 Global Nonsteroidal Anti-inflammatory APIs Production Capacity Market Share by Manufacturers (2016-2021)
• 2.2 Global Nonsteroidal Anti-inflammatory APIs Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Nonsteroidal Anti-inflammatory APIs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.4 Global Nonsteroidal Anti-inflammatory APIs Average Price by Manufacturers (2016-2021)
• 2.5 Manufacturers Nonsteroidal Anti-inflammatory APIs Production Sites, Area Served, Product Types
• 2.6 Nonsteroidal Anti-inflammatory APIs Market Competitive Situation and Trends
  • 2.6.1 Nonsteroidal Anti-inflammatory APIs Market Concentration Rate
  • 2.6.2 Global 5 and 10 Largest Nonsteroidal Anti-inflammatory APIs Players Market Share by Revenue
  • 2.6.3 Mergers & Acquisitions, Expansion

3 Production and Capacity by Region

• 3.1 Global Production Capacity of Nonsteroidal Anti-inflammatory APIs Market Share by Region (2016-2021)
• 3.2 Global Nonsteroidal Anti-inflammatory APIs Revenue Market Share by Region (2016-2021)
• 3.3 Global Nonsteroidal Anti-inflammatory APIs Production, Revenue, Price and Gross Margin (2016-2021)
• 3.4 North America Nonsteroidal Anti-inflammatory APIs Production
  • 3.4.1 North America Nonsteroidal Anti-inflammatory APIs Production Growth Rate (2016-2021)
  • 3.4.2 North America Nonsteroidal Anti-inflammatory APIs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
• 3.5 Europe Nonsteroidal Anti-inflammatory APIs Production
  • 3.5.1 Europe Nonsteroidal Anti-inflammatory APIs Production Growth Rate (2016-2021)
  • 3.5.2 Europe Nonsteroidal Anti-inflammatory APIs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
• 3.6 China Nonsteroidal Anti-inflammatory APIs Production
  • 3.6.1 China Nonsteroidal Anti-inflammatory APIs Production Growth Rate (2016-2021)
  • 3.6.2 China Nonsteroidal Anti-inflammatory APIs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
• 3.7 Japan Nonsteroidal Anti-inflammatory APIs Production
  • 3.7.1 Japan Nonsteroidal Anti-inflammatory APIs Production Growth Rate (2016-2021)
  • 3.7.2 Japan Nonsteroidal Anti-inflammatory APIs Production Capacity, Revenue, Price and Gross Margin (2016-2021)

4 Global Nonsteroidal Anti-inflammatory APIs Consumption by Region

• 4.1 Global Nonsteroidal Anti-inflammatory APIs Consumption by Region
  • 4.1.1 Global Nonsteroidal Anti-inflammatory APIs Consumption by Region
  • 4.1.2 Global Nonsteroidal Anti-inflammatory APIs Consumption Market Share by Region
• 4.2 North America
  • 4.2.1 North America Nonsteroidal Anti-inflammatory APIs Consumption by Country
  • 4.2.2 U.S.
  • 4.2.3 Canada
• 4.3 Europe
  • 4.3.1 Europe Nonsteroidal Anti-inflammatory APIs Consumption by Country
  • 4.3.2 Germany
  • 4.3.3 France
  • 4.3.4 U.K.
  • 4.3.5 Italy
  • 4.3.6 Russia
• 4.4 Asia Pacific
  • 4.4.1 Asia Pacific Nonsteroidal Anti-inflammatory APIs Consumption by Region
  • 4.4.2 China
  • 4.4.3 Japan
  • 4.4.4 South Korea
  • 4.4.5 Taiwan
  • 4.4.6 Southeast Asia
  • 4.4.7 India
  • 4.4.8 Australia
• 4.5 Latin America
  • 4.5.1 Latin America Nonsteroidal Anti-inflammatory APIs Consumption by Country
  • 4.5.2 Mexico
  • 4.5.3 Brazil

5 Production, Revenue, Price Trend by Type

• 5.1 Global Nonsteroidal Anti-inflammatory APIs Production Market Share by Type (2016-2021)
• 5.2 Global Nonsteroidal Anti-inflammatory APIs Revenue Market Share by Type (2016-2021)
• 5.3 Global Nonsteroidal Anti-inflammatory APIs Price by Type (2016-2021)

6 Consumption Analysis by Application

• 6.1 Global Nonsteroidal Anti-inflammatory APIs Consumption Market Share by Application (2016-2021)
• 6.2 Global Nonsteroidal Anti-inflammatory APIs Consumption Growth Rate by Application (2016-2021)

7 Key Companies Profiled

• 7.1 Mallinckrodt Pharmaceuticals
  • 7.1.1 Mallinckrodt Pharmaceuticals Nonsteroidal Anti-inflammatory APIs Corporation Information
  • 7.1.2 Mallinckrodt Pharmaceuticals Nonsteroidal Anti-inflammatory APIs Product Portfolio
  • 7.1.3 Mallinckrodt Pharmaceuticals Nonsteroidal Anti-inflammatory APIs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.1.4 Mallinckrodt Pharmaceuticals Main Business and Markets Served
  • 7.1.5 Mallinckrodt Pharmaceuticals Recent Developments/Updates
• 7.2 IOL
  • 7.2.1 IOL Nonsteroidal Anti-inflammatory APIs Corporation Information
  • 7.2.2 IOL Nonsteroidal Anti-inflammatory APIs Product Portfolio
  • 7.2.3 IOL Nonsteroidal Anti-inflammatory APIs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.2.4 IOL Main Business and Markets Served
  • 7.2.5 IOL Recent Developments/Updates
• 7.3 Lu'an Pharmaceutical
  • 7.3.1 Lu'an Pharmaceutical Nonsteroidal Anti-inflammatory APIs Corporation Information
  • 7.3.2 Lu'an Pharmaceutical Nonsteroidal Anti-inflammatory APIs Product Portfolio
  • 7.3.3 Lu'an Pharmaceutical Nonsteroidal Anti-inflammatory APIs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.3.4 Lu'an Pharmaceutical Main Business and Markets Served
  • 7.3.5 Lu'an Pharmaceutical Recent Developments/Updates
• 7.4 Novacyl
  • 7.4.1 Novacyl Nonsteroidal Anti-inflammatory APIs Corporation Information
  • 7.4.2 Novacyl Nonsteroidal Anti-inflammatory APIs Product Portfolio
  • 7.4.3 Novacyl Nonsteroidal Anti-inflammatory APIs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.4.4 Novacyl Main Business and Markets Served
  • 7.4.5 Novacyl Recent Developments/Updates
• 7.5 BASF
  • 7.5.1 BASF Nonsteroidal Anti-inflammatory APIs Corporation Information
  • 7.5.2 BASF Nonsteroidal Anti-inflammatory APIs Product Portfolio
  • 7.5.3 BASF Nonsteroidal Anti-inflammatory APIs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.5.4 BASF Main Business and Markets Served
  • 7.5.5 BASF Recent Developments/Updates
• 7.6 Anhui BBCA Pharmaceuticals
  • 7.6.1 Anhui BBCA Pharmaceuticals Nonsteroidal Anti-inflammatory APIs Corporation Information
  • 7.6.2 Anhui BBCA Pharmaceuticals Nonsteroidal Anti-inflammatory APIs Product Portfolio
  • 7.6.3 Anhui BBCA Pharmaceuticals Nonsteroidal Anti-inflammatory APIs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.6.4 Anhui BBCA Pharmaceuticals Main Business and Markets Served
  • 7.6.5 Anhui BBCA Pharmaceuticals Recent Developments/Updates
• 7.7 Xinhua Pharmaceutical
  • 7.7.1 Xinhua Pharmaceutical Nonsteroidal Anti-inflammatory APIs Corporation Information
  • 7.7.2 Xinhua Pharmaceutical Nonsteroidal Anti-inflammatory APIs Product Portfolio
  • 7.7.3 Xinhua Pharmaceutical Nonsteroidal Anti-inflammatory APIs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.7.4 Xinhua Pharmaceutical Main Business and Markets Served
  • 7.7.5 Xinhua Pharmaceutical Recent Developments/Updates
• 7.8 Granules India Limited
  • 7.8.1 Granules India Limited Nonsteroidal Anti-inflammatory APIs Corporation Information
  • 7.8.2 Granules India Limited Nonsteroidal Anti-inflammatory APIs Product Portfolio
  • 7.8.3 Granules India Limited Nonsteroidal Anti-inflammatory APIs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.8.4 Granules India Limited Main Business and Markets Served
  • 7.7.5 Granules India Limited Recent Developments/Updates
• 7.9 Changshu Huagang Pharmaceutical
  • 7.9.1 Changshu Huagang Pharmaceutical Nonsteroidal Anti-inflammatory APIs Corporation Information
  • 7.9.2 Changshu Huagang Pharmaceutical Nonsteroidal Anti-inflammatory APIs Product Portfolio
  • 7.9.3 Changshu Huagang Pharmaceutical Nonsteroidal Anti-inflammatory APIs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.9.4 Changshu Huagang Pharmaceutical Main Business and Markets Served
  • 7.9.5 Changshu Huagang Pharmaceutical Recent Developments/Updates
• 7.10 Hebei Jiheng Group
  • 7.10.1 Hebei Jiheng Group Nonsteroidal Anti-inflammatory APIs Corporation Information
  • 7.10.2 Hebei Jiheng Group Nonsteroidal Anti-inflammatory APIs Product Portfolio
  • 7.10.3 Hebei Jiheng Group Nonsteroidal Anti-inflammatory APIs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.10.4 Hebei Jiheng Group Main Business and Markets Served
  • 7.10.5 Hebei Jiheng Group Recent Developments/Updates
• 7.11 ZHEJIANG KANGLE PHARMACEUTICAL
  • 7.11.1 ZHEJIANG KANGLE PHARMACEUTICAL Nonsteroidal Anti-inflammatory APIs Corporation Information
  • 7.11.2 ZHEJIANG KANGLE PHARMACEUTICAL Nonsteroidal Anti-inflammatory APIs Product Portfolio
  • 7.11.3 ZHEJIANG KANGLE PHARMACEUTICAL Nonsteroidal Anti-inflammatory APIs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.11.4 ZHEJIANG KANGLE PHARMACEUTICAL Main Business and Markets Served
  • 7.11.5 ZHEJIANG KANGLE PHARMACEUTICAL Recent Developments/Updates
• 7.12 Hebei Jingye Medical Technology
  • 7.12.1 Hebei Jingye Medical Technology Nonsteroidal Anti-inflammatory APIs Corporation Information
  • 7.12.2 Hebei Jingye Medical Technology Nonsteroidal Anti-inflammatory APIs Product Portfolio
  • 7.12.3 Hebei Jingye Medical Technology Nonsteroidal Anti-inflammatory APIs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.12.4 Hebei Jingye Medical Technology Main Business and Markets Served
  • 7.12.5 Hebei Jingye Medical Technology Recent Developments/Updates
• 7.13 Hunan Zhongnan Pharmaceutical
  • 7.13.1 Hunan Zhongnan Pharmaceutical Nonsteroidal Anti-inflammatory APIs Corporation Information
  • 7.13.2 Hunan Zhongnan Pharmaceutical Nonsteroidal Anti-inflammatory APIs Product Portfolio
  • 7.13.3 Hunan Zhongnan Pharmaceutical Nonsteroidal Anti-inflammatory APIs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.13.4 Hunan Zhongnan Pharmaceutical Main Business and Markets Served
  • 7.13.5 Hunan Zhongnan Pharmaceutical Recent Developments/Updates

8 Nonsteroidal Anti-inflammatory APIs Manufacturing Cost Analysis

• 8.1 Nonsteroidal Anti-inflammatory APIs Key Raw Materials Analysis
  • 8.1.1 Key Raw Materials
  • 8.1.2 Key Raw Materials Price Trend
  • 8.1.3 Key Suppliers of Raw Materials
• 8.2 Proportion of Manufacturing Cost Structure
• 8.3 Manufacturing Process Analysis of Nonsteroidal Anti-inflammatory APIs
• 8.4 Nonsteroidal Anti-inflammatory APIs Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

• 9.1 Marketing Channel
• 9.2 Nonsteroidal Anti-inflammatory APIs Distributors List
• 9.3 Nonsteroidal Anti-inflammatory APIs Customers

10 Market Dynamics

• 10.1 Nonsteroidal Anti-inflammatory APIs Industry Trends
• 10.2 Nonsteroidal Anti-inflammatory APIs Growth Drivers
• 10.3 Nonsteroidal Anti-inflammatory APIs Market Challenges
• 10.4 Nonsteroidal Anti-inflammatory APIs Market Restraints

11 Production and Supply Forecast

• 11.1 Global Forecasted Production of Nonsteroidal Anti-inflammatory APIs by Region (2022-2027)
• 11.2 North America Nonsteroidal Anti-inflammatory APIs Production, Revenue Forecast (2022-2027)
• 11.3 Europe Nonsteroidal Anti-inflammatory APIs Production, Revenue Forecast (2022-2027)
• 11.4 China Nonsteroidal Anti-inflammatory APIs Production, Revenue Forecast (2022-2027)
• 11.5 Japan Nonsteroidal Anti-inflammatory APIs Production, Revenue Forecast (2022-2027)

12 Consumption and Demand Forecast

• 12.1 Global Forecasted Demand Analysis of Nonsteroidal Anti-inflammatory APIs
• 12.2 North America Forecasted Consumption of Nonsteroidal Anti-inflammatory APIs by Country
• 12.3 Europe Market Forecasted Consumption of Nonsteroidal Anti-inflammatory APIs by Country
• 12.4 Asia Pacific Market Forecasted Consumption of Nonsteroidal Anti-inflammatory APIs by Region
• 12.5 Latin America Forecasted Consumption of Nonsteroidal Anti-inflammatory APIs by Country

13 Forecast by Type and by Application (2022-2027)

• 13.1 Global Production, Revenue and Price Forecast by Type (2022-2027)
  • 13.1.1 Global Forecasted Production of Nonsteroidal Anti-inflammatory APIs by Type (2022-2027)
  • 13.1.2 Global Forecasted Revenue of Nonsteroidal Anti-inflammatory APIs by Type (2022-2027)
  • 13.1.3 Global Forecasted Price of Nonsteroidal Anti-inflammatory APIs by Type (2022-2027)
• 13.2 Global Forecasted Consumption of Nonsteroidal Anti-inflammatory APIs by Application (2022-2027)

14 Research Finding and Conclusion

15 Methodology and Data Source

• 15.1 Methodology/Research Approach
  • 15.1.1 Research Programs/Design
  • 15.1.2 Market Size Estimation
  • 15.1.3 Market Breakdown and Data Triangulation
• 15.2 Data Source
  • 15.2.1 Secondary Sources
  • 15.2.2 Primary Sources
• 15.3 Author List